Literature DB >> 8543840

Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope proteins.

R L Ferris1, C Buck, S A Hammond, A S Woods, R J Cotter, M Takiguchi, Y Igarashi, Y Ichikawa, R F Siliciano.   

Abstract

Uncertainty exists over the site of processing of viral envelope (env) proteins for recognition by CTL. The extracellular domains of env proteins are not present in the cytosol, the site where the class I Ag processing pathway begins. Rather, the ecto-domains of env proteins are cotranslationally translocated into the endoplasmic reticulum during biosynthesis. To clarify the site of processing of viral env proteins, we examined the processing of an HLA B*3501-restricted epitope in the extracellular domain of the HIV-1 env protein. Although this epitope contains an N-linked glycosylation signal sequence, CTL specific for this epitope recognize a nonameric peptide that has not been previously modified by attachment of oligosaccharide. This was demonstrated in two ways. First, an env-specific B*3501-restricted CTL clone recognized a nonglycosylated, synthetic nonamer representing the minimal B*3501-restricted epitope, but not the glycosylated or deglycosylated forms. Second, the naturally processed, B*3501-restricted, env peptide is identical with a nonglycosylated, synthetic nonamer. Thus, the naturally processed form of an env epitope containing an N-linked glycosylation site is derived from env protein that is not glycosylated at the relevant asparagine during biosynthesis. Since the addition of N-linked oligosaccharides occurs only after the glycosylation signal sequence (N-X-S/T) is translocated into the endoplasmic reticulum, the initial processing reaction for this epitope may take place in the cytosol. Low-frequency failure of signal sequence containing polypeptides to engage the translocation apparatus, resulting in synthesis and degradation in the cytosol, may represent an important mechanism for the generation of class I-restricted CTL responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8543840

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1.

Authors:  N V Sipsas; S A Kalams; A Trocha; S He; W A Blattner; B D Walker; R P Johnson
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Kinetically distinct processing pathways diversify the CD8+ T cell response to a single viral epitope.

Authors:  Gabriela L Cosma; Jenna L Lobby; Elizabeth J Fay; Nicholas A Siciliano; Ryan A Langlois; Laurence C Eisenlohr
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

3.  Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.

Authors:  S A Hammond; S J Cook; D L Lichtenstein; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  Prediction of potential cytotoxic T lymphocyte epitopes of bovine herpesvirus 1 based on allele-specific peptide motifs and proteolytic cleavage specificities.

Authors:  N R Hegde; S Srikumaran
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

5.  Novel immunogenic HLA-A*0201-restricted epidermal growth factor receptor-specific T-cell epitope in head and neck cancer patients.

Authors:  Pedro A Andrade Filho; Andrés López-Albaitero; William Gooding; Robert L Ferris
Journal:  J Immunother       Date:  2010-01       Impact factor: 4.456

6.  The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol.

Authors:  C A Mosse; L Meadows; C J Luckey; D J Kittlesen; E L Huczko; C L Slingluff; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

7.  Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?

Authors:  Alex Olvera; Samandhy Cedeño; Anuska Llano; Beatriz Mothe; Jorge Sanchez; Gemma Arsequell; Christian Brander
Journal:  Front Immunol       Date:  2021-01-22       Impact factor: 7.561

8.  Systematic characterisation of cellular localisation and expression profiles of proteins containing MHC ligands.

Authors:  Agnieszka S Juncker; Mette V Larsen; Nils Weinhold; Morten Nielsen; Søren Brunak; Ole Lund
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.